Skip to main content
SpringerLink
Log in

Idiopathische pulmonale Fibrose

Neue Ansätze zur Verzögerung der Krankheitsprogression

  • infopharm
  • Published:
Pneumo News Aims and scope

Die idiopathische Lungenfibrose (IPF) ist eine bisher kaum behandelbare interstitielle Pneumonie. Neue zielgerichtete Therapien können die unkontrollierte Fibroblastenproliferation aber bremsen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Behr J et al. Pneumologie 2013; 67: 81–111.

    Article  CAS  PubMed  Google Scholar 

  2. Vancheri C et al. Eur Respir J 2010; 35: 496–504.

    Article  CAS  PubMed  Google Scholar 

  3. Richeldi L et al. N Engl J Med 2014; 370: 2071–82.

    Article  PubMed  Google Scholar 

Quelle

  • Satellitensymposium 56. DGP-Kongress, Berlin, 19.3.2015; Veranstalter: Boehringer Ingelheim

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Abdol A. Ameri

Authors
  1. Abdol A. Ameri
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ameri, A.A. Neue Ansätze zur Verzögerung der Krankheitsprogression. Pneumo News 7, 66 (2015). https://doi.org/10.1007/s15033-015-0169-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-015-0169-9

Search

Navigation